Top headlines: Companies hold back on capex, GST mop-up at record high

Business Standard brings you top news of the evening

AstraZeneca vaccine set to become first to get approval in India: Report

India’s drug regulator is set to approve on Friday a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, three sources with knowledge of the matter said. The decision would pave the way for the vaccine’s rollout in the world’s second-most populous country which, after the United States, has the highest number of COVID-19 infections in the world. Britain and Argentina have already authorised the vaccine for urgent public use. Read more

GST mop up rose to highest ever level at over Rs 1.15